Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma
NCT01346787Phase 2Completed
- Start
- Jul 2011
- Primary completion
- Oct 2012
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM). Started Jul 2011; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01346787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346787.